An interventional study of Community Based administration of DMPA in Contraception, Family Planning and Task Shifting, sponsored by University of California, Berkeley. Completed at 3 sites in Ethiopia. Open to female participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-02-15.
Sponsored by University of California, Berkeley · Not applicable, Interventional, and Health services research
The purpose of this study was to demonstrate that with appropriate training, the provision of injectable contraceptives by community based reproductive health agents (CBRHAs) does not significantly differ from low-level clinic-based providers, or health extension workers (HEWs).
The overall goal of this project was to increase contraceptive prevalence and reduce the current high unmet need for family planning in rural areas of Ethiopia. In addition, the project was intended to provide evidence to policy makers to expand community based distribution (CBD) of the injectible contraceptive, depot medroxyprogesterone acetate (DMPA), in both Tigray and other regions of Ethiopia where community based reproductive health agents (CBRHAs) or other community health workers (CHWs) are present.
Following from that, the specific aims of this project were to:
University of California, Berkeley is the lead sponsor of 106 studies on the registry; 18 are open to participants now.
Of its 5 completed or terminated interventional studies of FDA-regulated products, 1 (20%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Women who receive injectable contraceptive from clinic based health extension workers (HEWs) during the study period
Other: Community Based administration of DMPA
Women who receive injectable contraceptive through community based distributors from community based reproductive health agents (CBRHAs) during the study period
Other: Community Based administration of DMPA
Injectable contraceptive administered by clinic based health extension worker or community based reproductive health agent using same protocol to test equivalence of community based distribution to facility based distribution
Equivalence of injection administration
Injection site morbidities, induration etc
Time frame: every 3 months
Equivalent continuation rates
Follow up injection rates at 2nd and 3rd injection.
Time frame: Every 3 months
Knowledge of side effects among clients
The clients understand the efficacy, the drug usage, side effects and recourse for care if side effects manifest at 13 week and 6 month questionnaire
Time frame: Every 3 months
This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of California, Berkeley